STRATA CRITICAL MEDICAL, INC. Share-based Payment Arrangement, Expense
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Share-based Payment Arrangement, Expense of $5.34 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-11-12
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $5.34M, a 60.51% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $5.55M, a 98.28% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $4.54M, a 57.63% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was $3.33M, a 97.63% increase year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $5.34M 10-Q · filed 2024-11-12 | $10.89M derived: sum of 2 quarters · filed 2024-11-12 | $15.43M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.55M 10-Q · filed 2024-08-08 | $10.09M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.54M 10-Q · filed 2024-05-07 | ||
| 2023-09-30 | $3.33M 10-Q · filed 2024-11-12 | $6.13M derived: sum of 2 quarters · filed 2024-11-12 | $9.01M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $2.80M 10-Q · filed 2024-08-08 | $5.68M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $2.88M 10-Q · filed 2024-05-07 | ||
| 2022-09-30 | $1.69M 10-Q · filed 2023-11-08 | $3.53M derived: sum of 2 quarters · filed 2023-11-08 | $5.63M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $1.84M 10-Q · filed 2023-08-09 | $3.94M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $2.10M 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $3.92M 10-Q · filed 2022-11-10 | $6.44M derived: sum of 2 quarters · filed 2022-11-10 | $8.35M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $2.52M 10-Q · filed 2022-08-09 | $4.42M 10-Q · filed 2022-08-09 | $5.70M 10-Q · filed 2021-08-16 |
| 2020-06-30 | $268.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |